Canaccord Genuity raises Regeneron target price to $922 from $875
REGN•Canaccord Genuity raised its target price for Regeneron Pharmaceuticals to $922 from $875.
Related News
Central Pacific Financial Q3 profit rises on higher interest income
CPF•
Enphase Energy: Susquehanna cuts target price to $26 from $35
ENPH•
Prescient favors South African bonds as real yields exceed 4%
TLT•
Hubbell: Mizuho cuts target price to $515 from $560
HUBB•
Polaris Inc: BMO cuts target price to $60 from $70
PII•